Research News - July 2, 2015

Neuroscience Microscope Core

Directors: Cristopher Bragg
Locations: Building 149 13th Street, Room 6028B, Charlestown

The Neuroscience Microscope Core offers laser confocal microscopy services. This Core consists of a Zeiss LSM 5 Pascal laser confocal microscope. The Zeiss RGB vario laser module consists of argon laser (458/488/514 nm) and two helium-neon lasers (543 and 633 nm). A Zeiss Axiovert 200 fully motorized light microscope is available with fluorescence, bright-field, phase-contrast and Nomarski (DIC) capabilities. Image acquisition and analyses are performed using Zeiss LSM 5 Pascal Confocal Microscopy Software (Release 3.2) on 2 workstations. Zeiss Physiology software is available also. Live cell imaging is available using a Zeiss temperature controller with custom chamber and heating stage.

For more information about the Neuroscience Microscope Core please click here.

Beginning 6/26/15, the CCM animal orientation and facility access training course will be offered exclusively online via Heathstream. For more information, please click here

Please click here to read the latest news from the Patient-Centered Outcomes Research Institute.

As many of you know, we conducted a RAG System Days Survey within the Partners HealthCare organization and hospitals to determine the level of interest within our user community around system updates and projects that relate to our research administrative systems – InfoEd, Insight, Navigator, and MicroStrategy.

Thank you to everyone that participated! Your feedback was appreciated and helped validate holding the RAG System Days. Please click he​re for the Survey results.

RAG System Days (InfoEd, Insight, MicroStrategy)

The RAG System Days will focus on InfoEd, Insight, and MicroStrategy be held on:​

• MGH – Tuesday July 28th @ Haber Auditorium and
• BWH – Monday August 3rd @ Duncan Reid Auditorium

All PHS employees that are interested in attending please click here to sign up.

Research Navigator Q & A
Research Navigator Q & A sessions will be held separately on the following days:​

• MGH – 7/27 10AM-12PM, 1PM-3PM (Haber Auditorium)
• BWH – 7/28 10AM-12PM, 2:30PM-4:30PM (70 Francis Street – Shapiro Boardroom)​
• PHS Central Offices – 7/29 1PM-4PM (Minot Conference Room)

​ ​All PHS employees that are interested in attending the Navigator Q & A please click here to sign up.

The Executive Committee on Research (ECOR) is accepting applications for the August 1st deadline for the Deliberative Interim Support Funding g.  August is the second of three standing deadlines for these awards in 2015. The next deadline will be December 1, 2015.  

What are they?
Deliberative Interim Support Funding
This is open to Principal Investigators during a lapse or delay in their research funding from the NIH or another Federal agency (e.g., the National Science Foundation, the Department of Defense).  Investigators must have applied for independent, long-term support (R01, R21, U01 and P01).  The Deliberative Interim Support process is open to:

1. Investigators whose grants were not scored or whose scores were not translated into a percentile ranking.
2. Investigators whose grants received scores >20th percentile.
3. Investigators who were awarded Formulaic Bridge Funding (grants with scores < or = 20th percentile), and are now requesting additional financial support (in excess of $75,000 for RO1s, and $37,500 for R21s).
4. Investigators who have already received Formulaic Bridge Funding or Deliberative Interim Support on their A0 grant application and are now requesting support for their A1 or A0 resubmission.  Investigators in this category must apply through the Deliberative Interim Support process for their A1 and A0 resubmission regardless of the score they received on their resubmitted grant.

When is the deadline?
Saturday, August 1, 2015 - 5:00 PM

How do I learn more and apply?
Deliberative Interim Support Funding - Click here

Please contact Corporate & Foundation Relations in the Office of Development at devcfr@mgh.harvard.edu if you wish to submit a proposal in response to any of these funding opportunities.  Note that proposals are still routed through the standard InfoEd/Research Management process.

• Investment Grants:  Exploring HIV Persistence and Eradication, amfAR, The Foundation for AIDS Research
• Beckman Young Investigators (BYI) Program, Arnold and Mabel Beckman Foundation
• Leroy Matthews Physician/Scientist Award, Cystic Fibrosis Foundation (CFF)
• Career Awards at the Scientific Interface (CASI), Burroughs Wellcome Fund (BWF)
• OREF Clinical Research Grant in Hip and Knee Arthroplasty Infection, Orthopaedic Research and Education Foundation (OREF)
• Harry Schwachman Clinical Investigator Award, Cystic Fibrosis Foundation (CFF)
• Research Project Grants, Cerebral Palsy Alliance/Research Foundation
• Translational Research Grant Program (HeART (Help Accelerate RTT Therapeutics) ), Rettsyndrome.org (International Rett Syndrome Foundation)
• New Investigator Grant, Scleroderma Foundation
• Postdoctoral Fellowship, Hope Funds for Cancer Research
• Fund-a-Fellow (FAF) Postdoctoral Grant Program, Myotonic Dystrophy Foundation (MDF)
• Mentored Training Fellowship Program, Rettsyndrome.org (International Rett Syndrome Foundation)
• Basic Research Grant Program, Rettsyndrome.org (International Rett Syndrome Foundation)

Please click here for further details on these funding opportunities.

We ask that all MGH Investigators interested in applying for any limited submission award submit a Letter of Intent (see detailed instructions below) to the MGH Executive Committee on Research (ECOR) by the deadline indicated for each award to be considered to receive an institutional nomination.

Process
Submit a one- to two-page Letter of Intent (LOI) to the MGH Executive Committee on Research (ECOR) via email to ecor@partners.org.  In addition to your LOI, please include an NIH Biosketch.

The letter of intent should include:

• Name of the Principal Investigator with appropriate contact information
• A descriptive title of the potential application
• Brief description of the project
• Brief description of why you specifically should be selected to receive institutional nomination for this award

In the event that there is more than one MGH investigators interested in applying for each limited submission award, the LOIs will be used to assess candidates and a review and selection process will take place.

Current Limited Submission Funding Opportunities
Please click here for more information and for our internal deadlines.

• Asthma and Allergic Diseases Cooperative Research Centers (U19)
• Career Development Program in Emergency Care Research (K12)
• Career Development Programs in Diabetes Research for Pediatric Endocrinologists (K12)

If there is a limited submission funding opportunity you do not see listed above or you have any additional questions, please contact Erin McGivney at 617-643-6471.

For the latest National Institutes of Health notices, requests for applications, and program announcements, follow this link: http://grants.nih.gov/grants/guide/WeeklyIndex.cfm

MGH ECOR Formulaic Bridge Funding
Application Deadline: July 7, 7th day of each month

Boston Biomedical Innovation Center (B-BIC) Accepting PILOT & DRIVE Grant Pre-Proposals

Clinical Research Spotlight Series: Study Coordinator Discussion Group – July 15

Research Subject Remuneration and Reimbursement: Policy Review – August 4

Looking for something you saw in a previous Research News release? Check out our archive!